Market revenue in 2023 | USD 247.2 million |
Market revenue in 2030 | USD 411.4 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | Formulation development |
Fastest growing segment | Formulation Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preformulation, Formulation Development |
Key market players worldwide | SGS, Intertek Group PLC, Recipharm, Lonza Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Element Solutions Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Catalent Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to formulation development outsourcing market will help companies and investors design strategic landscapes.
Formulation development was the largest segment with a revenue share of 76.82% in 2023. Horizon Databook has segmented the Switzerland formulation development outsourcing market based on preformulation, formulation development covering the revenue growth of each sub-segment from 2018 to 2030.
The well-developed healthcare infrastructure and R&D facilities make Switzerland one of the most lucrative markets globally. The country is one of Europe’s major drug development hubs, with 90.0% export production.
In addition, the country is one of the innovative biotechnology hubs, with the pharmaceutical & biotechnology sector accounting for nearly 40% of the country’s exports. The production cost is relatively low compared to countries such as the UK & Germany as most of the manufacturing in the country is done through contract manufacturers, facilitating the demand for services such as formulation development outsourcing.
Furthermore, the country is home to two of the leading multinational companies—Roche and Novartis AG —which are involved in several R&D activities. For instance, Novartis has more than 200 projects in the clinical pipeline.
Horizon Databook provides a detailed overview of country-level data and insights on the Switzerland formulation development outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Switzerland formulation development outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account